Pulse Biosciences CS (PLSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 401 | 264 | 86 | 0 | 0 |
| Cost of Goods | 370 | 260 | 279 | N/A | N/A |
| Gross Profit | 31 | 4 | -193 | N/A | N/A |
| Operating Expenses | 19,551 | 18,517 | 20,453 | 20,275 | 18,044 |
| Operating Income | -19,150 | -18,253 | -20,367 | -20,275 | -18,044 |
| Other Income | 569 | 820 | 982 | 1,107 | 1,249 |
| Pre-tax Income | -18,581 | -17,433 | -19,385 | -19,168 | -16,795 |
| Net Income Continuous | -18,581 | -17,433 | -19,385 | -19,168 | -16,795 |
| Net Income | $-18,581 | $-17,433 | $-19,385 | $-19,168 | $-16,795 |
| EPS Basic Total Ops | -0.27 | -0.26 | -0.29 | -0.28 | -0.25 |
| EPS Basic Continuous Ops | -0.27 | -0.26 | -0.29 | -0.28 | -0.25 |
| EPS Diluted Total Ops | -0.27 | -0.26 | -0.29 | -0.28 | -0.25 |
| EPS Diluted Continuous Ops | -0.27 | -0.26 | -0.29 | -0.28 | -0.25 |
| EPS Diluted Before Non-Recurring Items | -0.27 | -0.26 | -0.29 | -0.28 | -0.25 |
| EBITDA(a) | $-18,895 | $-17,994 | $-20,111 | $-20,002 | $-17,761 |